Andro Classified As Controlled Substance In Senate Bill; DHEA Excluded
This article was originally published in The Tan Sheet
Executive Summary
Androstenedione would be regulated as a controlled substance under legislation offered by Sen. Joseph Biden (D-Del.), and co-sponsored by Sens. Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Charles Grassley (R-Iowa)
You may also be interested in...
Steroid class action certified on appeal
A California appellate court in Los Angeles sides with a class action certification attempt on appeal against GNC about steroid-containing supplements. The court's Jan. 21 1decision reverses a lower court's rejection of plaintiff Diego Martinez's class certification attempt. The previous rejection was based on an erroneous legal assumption - "that common issues did not predominate because class members would be required to individually litigate issues of causation and injury." Martinez attempted to certify a class of anyone who purchased products from GNC containing androstenediol in California between 2000 and 2004. He alleged damages based on GNC's deceptive conduct. GNC said it ceased selling so-called supplements with androstenediol, a schedule III controlled substance, in March 2004 (2"The Tan Sheet" Oct. 27, 2003)
DHEA Debate Returns To Fore: Anabolic Steroid Status Sought In Grassley Bill
A new bill sponsored by Sen. Charles Grassley (R-Iowa) would regulate dehydroepiandrosterone (DHEA) as an anabolic steroid under the Controlled Substances Act
Put DHEA Under DEA, Amend DSHEA, Waxman Says At Andro Bill Markup
Dehydroepiandrosterone's exemption from the controlled substances list in the Anabolic Steroid Control Act of 2004 is likely to be challenged when the bill moves to the House floor